Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis? Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T Neuropsychiatr Dis Treat. 2012; 8:465-73. Epub 2012 Oct 23. PMID: 23118540. Abstract CommentRecommendBookmarkWatch